RxDoctor Payments Data

Karla Dwyer

Gerontology · Wichita Falls, TXNPI 1588175624

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,617in general payments, 2019–2025

Across 196 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$784
  • Abiomed$620
  • Boehringer Ingelheim$559
  • Novartis$392
  • AstraZeneca$363
  • Edwards Lifesciences$339
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$4,612100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,617 in reported general payments places this provider in the 90th percentile of 653 gerontology providers in Texas.

See all gerontology providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
CamzyosMavacamten17$141,423
EliquisApixaban131$127,517
JardianceEmpagliflozin36$26,912
XareltoRivaroxaban25$22,533
EntrestoSacubitril/Valsartan21$21,231
Repatha SureclickEvolocumab21$21,005
FarxigaDapagliflozin Propanediol15$11,075
BrilintaTicagrelor14$6,323
Praluent PenAlirocumab11$5,879
Metoprolol Succinate336$4,498
Dabigatran EtexilateDabigatran Etexilate Mesylate13$4,212
Valsartan156$4,066
Ezetimibe40$2,014
Amiodarone Hcl65$1,693
Ranolazine ErRanolazine30$1,574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
E.r. Squibb & Sons, L.L.C.Camzyos$784$141,42317 claims
PfizerEliquis$184$127,517131 claims
Boehringer IngelheimJardiance$559$26,91236 claims
Johnson & JohnsonXarelto$161$22,53325 claims
NovartisEntresto$392$21,23121 claims
AstraZenecaFarxiga, Brilinta$363$17,39829 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 653 gerontology providers in Texas.

Other gerontology in Wichita Falls

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →